• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

动脉内化疗的非典型事件剖析

Atypical Event Profiling of Intra-Arterial Chemotherapy.

作者信息

Bach Austin, Villegas Victor M, Gold Aaron S, Murray Timothy G

机构信息

Nova Southeastern University/Larkin Community Hospital, Miami, FL, USA.

University of South Florida Morsani College of Medicine, Tampa, FL, USA.

出版信息

J Vitreoretin Dis. 2022 May 20;6(3):251-254. doi: 10.1177/24741264221083411. eCollection 2022 May-Jun.

DOI:10.1177/24741264221083411
PMID:37008552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9976131/
Abstract

PURPOSE

Three cases of atypical events following intra-arterial chemotherapy for the treatment of retinoblastoma are presented.

METHODS

Case report.

RESULTS

One patient had acute orbital swelling with proptosis, another with extravasation of the chemotherapeutic agent, and the final with total ipsilateral hearing loss.

CONCLUSIONS

These cases underscore the importance of maintaining close follow-up when using intra-arterial chemotherapy for treatment of retinoblastoma.

摘要

目的

报告3例视网膜母细胞瘤动脉内化疗后出现的非典型事件。

方法

病例报告。

结果

1例患者出现急性眼眶肿胀伴眼球突出，另1例出现化疗药物外渗，最后1例出现同侧完全性听力丧失。

结论

这些病例强调了在使用动脉内化疗治疗视网膜母细胞瘤时进行密切随访的重要性。

相似文献

1
Atypical Event Profiling of Intra-Arterial Chemotherapy.动脉内化疗的非典型事件剖析
J Vitreoretin Dis. 2022 May 20;6(3):251-254. doi: 10.1177/24741264221083411. eCollection 2022 May-Jun.
2
Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.初始动脉内化疗后视网膜母细胞瘤复发后的挽救性动脉内化疗。
J Fr Ophtalmol. 2015 Jun;38(6):542-9. doi: 10.1016/j.jfo.2015.03.004. Epub 2015 May 14.
3
Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.视网膜母细胞瘤的动脉内化疗：单中心经验
Ophthalmologica. 2015;234(4):227-32. doi: 10.1159/000439357. Epub 2015 Sep 15.
4
Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma.超选择性动脉内化疗：晚期视网膜母细胞瘤治疗相关并发症的评估
Clin Ophthalmol. 2011;5:171-6. doi: 10.2147/OPTH.S12665. Epub 2011 Feb 10.
5
Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.视网膜母细胞瘤的替代治疗：美法仑动脉内化疗。
Arch Soc Esp Oftalmol. 2015 Oct;90(10):487-90. doi: 10.1016/j.oftal.2015.04.004. Epub 2015 May 23.
6
Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.交替动脉内和玻璃体内化疗治疗晚期眼内视网膜母细胞瘤：未进行全身化疗的初步成功结果。
Int Ophthalmol. 2015 Dec;35(6):887-95. doi: 10.1007/s10792-015-0129-8. Epub 2015 Sep 28.
7
Spontaneously Resolving Periocular Erythema and Ciliary Madarosis Following Intra-arterial Chemotherapy for Retinoblastoma.视网膜母细胞瘤动脉内化疗后自发消退的眼周红斑和睫状睫毛脱落
Middle East Afr J Ophthalmol. 2010 Jul;17(3):207-9. doi: 10.4103/0974-9233.65492.
8
The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.拓扑替康联合马法兰治疗眼内动脉化疗的视网膜母细胞瘤。
Ophthalmol Retina. 2021 Aug;5(8):824-830. doi: 10.1016/j.oret.2020.11.007. Epub 2020 Nov 19.
9
Risk factors for severe neutropenia following intra-arterial chemotherapy for intra-ocular retinoblastoma.眼内视网膜母细胞瘤动脉内化疗后严重中性粒细胞减少的危险因素。
PLoS One. 2014 Oct 10;9(10):e108692. doi: 10.1371/journal.pone.0108692. eCollection 2014.
10
Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.经动脉内化疗治疗眼内视网膜母细胞瘤：直接眼动脉插管治疗的替代方法。
AJNR Am J Neuroradiol. 2012 Sep;33(8):1608-14. doi: 10.3174/ajnr.A3019. Epub 2012 Mar 22.

引用本文的文献

1
Update on Retinoblastoma Therapies.视网膜母细胞瘤治疗进展
Medicina (Kaunas). 2025 Jul 4;61(7):1219. doi: 10.3390/medicina61071219.

本文引用的文献

1
Retinoblastoma: achieving new standards with methods of chemotherapy.视网膜母细胞瘤：通过化疗方法实现新的标准
Indian J Ophthalmol. 2015 Feb;63(2):103-9. doi: 10.4103/0301-4738.154369.
2
Outcome of retinoblastoma following limited sessions of intra-arterial chemotherapy in iran.伊朗有限疗程动脉内化疗后视网膜母细胞瘤的治疗结果
Iran J Radiol. 2014 Aug;11(3):e16958. doi: 10.5812/iranjradiol.16958. Epub 2014 Aug 1.
3
Complications of intra-arterial chemotherapy for retinoblastoma.视网膜母细胞瘤动脉内化疗的并发症
Semin Ophthalmol. 2014 Sep-Nov;29(5-6):429-33. doi: 10.3109/08820538.2014.959188.
4
Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma.视网膜母细胞瘤动脉内化疗的要点与陷阱
J Neurosurg Pediatr. 2012 Sep;10(3):175-81. doi: 10.3171/2012.5.PEDS1277. Epub 2012 Jul 13.
5
A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.一项关于美法仑经动脉（眼动脉）直接化疗用于眼内视网膜母细胞瘤的I/II期研究：初步结果
Ophthalmology. 2008 Aug;115(8):1398-404, 1404.e1. doi: 10.1016/j.ophtha.2007.12.014. Epub 2008 Mar 14.
6
The treatment of retinoblastoma by x-ray and triethylene melamine.用X射线和三乙烯三聚氰胺治疗视网膜母细胞瘤。
AMA Arch Ophthalmol. 1958 Nov;60(5):897-906. doi: 10.1001/archopht.1958.00940080917010.
7
Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay.
Jpn J Cancer Res. 1987 Aug;78(8):858-68.